Flying The Web For News.
  • Epiphany
    Epiphany
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Details
Category: Globe NewsWire News Distribution Service

~ Achieved Second Quarter 2024 Total Net Revenues of $7.3 Million ~ ~ Appointed Jeffrey S. Hackman as Chief Executive Officer (CEO) and Member of the Board of Directors ~ ~ Company Has Approximately $43 Million in Cash, Cash Equivalents, and Investment Securities ~


Posted: 2024-08-13 10:05:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | fennec | pharmaceuticals | reports


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - Newscast

Fennec Pharmaceuticals Inc. (FENC)

Sun, 05 Jan 2025 16:00:00 GMT today announced the early repayment of $13 million of the Company’s approximately $32 million outstanding convertible debt facility with Petricho Fennec Pharmaceuticals Inc (FENC) reports ...

Wedbush Boosts Earnings Estimates for Fennec Pharmaceuticals

Wed, 25 Dec 2024 15:59:00 GMT Fennec Pharmaceuticals has a 12 month low of C$5.65 and a 12 month high of C$15.43. In other news, Director Rostislav Christov Raykov purchased 25,000 shares of Fennec Pharmaceuticals stock in a ...

Fennec Pharmaceuticals Inc. (FENC)

Tue, 24 Dec 2024 05:00:00 GMT Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2024 financial results before ...

Fennec Pharmaceuticals Inc FENC

Fri, 20 Dec 2024 03:16:00 GMT We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

Optimistic Growth Prospects for Fennec Pharmaceuticals Amidst Financial Challenges

Mon, 16 Dec 2024 21:15:00 GMT Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Fennec Pharmaceuticals (FENC – Research Report). The associated price target is $13.00. Discover top-rated stocks ...


Blow Us A Whistle